Barchart Demo Center

Overview

Stocks

Stock Screeners

ETFs

Futures

Funds

Fund Screeners

Foreign Exchange

Sectors

News

Financial Calculators

Embedded Widgets

Portfolio

Screener

JSON Feeds

Symbol Overview

United States|Canada
English|French

Aeon Biopharma Inc

(AMEX: AEON)
Add to Portfolio
+0.1400 (+9.72%)
as of May 31, 2024

Values in US Thousands
  12-2023 12-2022 12-2021 12-2020
Operating Expenses 86 48,429 1,936 4
Operating Income -86 -48,429 -1,936 -4
Other Income/Expenses -36,546 -4,127 10,137 -
Pre-tax Income -36,632 -52,556 8,201 -4
Net Income from Cont. Operations -36,632 -52,556 8,201 -4
Total Net Income $ -36,632 $ -52,556 $ 8,201 $ -4
Basic EPS from Cont. Ops. -0.99 -0.38 1.20 0.00
Basic EPS from Total Ops. -0.99 -0.38 0.26 -
Diluted EPS from Cont. Ops -0.99 -0.38 1.20 0.00
Diluted EPS from Total Operations -0.99 -0.38 0.26 -
EBITDA 13 -48,361 -1,936 -4